What is PhytogenX?
PhytogenX operates as a contract manufacturer specializing in skin care products, boasting a substantial 110,000 sqf facility. The company's operations are underpinned by stringent certifications, including FDA, medical devices, and OTC compliance. Furthermore, PhytogenX houses a dedicated laboratory staffed by six chemists, equipped to support clients in product creation, enhancement, and reverse-engineering. This comprehensive service offering positions PhytogenX as a key player for brands seeking to develop or refine their skincare lines, emphasizing a commitment to safety and quality as foundational to client success.
How much funding has PhytogenX raised?
PhytogenX has raised a total of $2.2M across 2 funding rounds:
Debt
$1M
Debt
$1.2M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.2M led by PPP
Key Investors in PhytogenX
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for PhytogenX?
The recent major strategic investment positions PhytogenX for an accelerated phase of growth and operational expansion. With its robust manufacturing infrastructure and certified laboratory capabilities, the company is well-equipped to capitalize on increasing market demand for specialized skincare products. Future endeavors will likely focus on enhancing production capacity, potentially expanding its service offerings to include more advanced formulations or packaging solutions, and solidifying its partnerships within the enterprise-level beauty and wellness sectors. This strategic backing is expected to fuel innovation and reinforce PhytogenX's competitive edge.
See full PhytogenX company page
